Magnitude Biosciences started operations in September 2018 to commercialise a Durham University ageing research technology centred on the C.elegans nematode worm.

Magnitude Biosciences, a UK-based ageing research company spun out of Durham University, yesterday received £150,000 ($194,000) in a round featuring the EU-backed North East Innovation Fund. Saker Capital, a speciality real estate investment and advisory firm, also supplied Magnitude with funding. Founded in September 2018, Magnitude Biosciences is progressing research into compounds such as food…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.